BibTex RIS Kaynak Göster

-

Yıl 2006, Cilt: 19 Sayı: 2, 80 - 85, 26.06.2015

Alper Çelik Suat Kutun Turgay Fen Gülay Bilir Akın Önder Abdullah Çetin

Öz

-

Anahtar Kelimeler

-

Kaynakça

  • 1. Panosetti E, Luboinski B, Mamelle G, et al. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study. Laryngoscope 1989; 99: 1267-73.
  • 2. Warren S, Gates O. Multiple malignant tumors: a survey of literature and statistical study. Am J Cancer 1932; 51: 1358-414.
  • 3. Van Leeuwen FE, Travis LB. Second Cancers. In: Cancer Principle and Practice of Oncolgy. DeVita VT Jr, Hellman S, Rosenberg SA, Eds, 7th Edition. WW Lippincott, Philadelphia, 2005: 2575-2602.
  • 4. Boice JD, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer – an international collaboration among cancer registries. J Natl Cancer Inst 1985; 74 (5): 955-75.
  • 5. Brenner DJ, Curtis RE, Hall EJ, et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000; 88(2): 398-406.
  • 6. Dhooge IJ, DeVos M, VanCauwenberge PB. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 1998; 108 (2): 250-6.
  • 7. Wei-wei L, Qiu-liang W, Guo-hao W, et al. Clinicopathologic features, treatment, and prognosis of postirradiation osteosarcoma in patients with nasopharyngeal cancer. Laryngoscope 2005;115(9):1574-9.
  • 8. Sanz C, Moreno F, Armas A, Casado A, Castillo MC. Groin angiosarcoma following radiotherapy for vulvar cancer. Gynecol Oncol. 2005 May;97(2):677-80.
  • 9. Eggers G, Flechtenmacher C, Kurzen H, Hassfeld S. Infiltrating basal cell carcinoma of the neck 34 years after irradiation of an haemangioma in early childhood. J Craniomaxillofac Surg 2005; 33(3):197-200.
  • 10. Van Leeuwen FE, Klokman WJ, Stovall M, et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin’s disease. J Natl Cancer Inst 1995; 87(20): 1502-3.
  • 11. Boivin JF, Hutchison GB, Zauber AG, et al. Incidence of second cancers in patients treated for Hodgkin’s disease. J Natl Cancer Inst 1995; 87(10): 732-41.
  • 12. Lorigan P, Radford J, Howell A, Thatcher N. Lung cancer after treatment for Hodgkin’s lymphoma: a systematic review. Lancet Oncol 2005; 6: 773-9.
  • 13. Kaldor J, Day N, Bell J, et al. Lung cancer following Hodgkin’s disease: a case control study. Int J Cancer 1992; 52: 677-81.
  • 14. Travis L, Gospodarowicz M, Curtis R, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst 2002; 94: 182-91.
  • 15. Gilbert E, Stowall M, Gospodarowicz M, et al. Lung cancer after treatment for Hodgkin’s disease: focus on radiation effects. Radiat Res 2003; 159: 161-73.
  • 16. Sachs RK, Brenner DJ. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci USA 2005; 102 (37): 13040-45.
  • 17. Perkins JL, Liu Y, Mitby PA, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol 2005;23 (16): 3733-41.
  • 18. Karagas MR, McDonald JA, Greenberg ER, et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 1996; 88(24):1848-53.
  • 19. Katz KA, Marcil I, Stern RS. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients. J Invest Dermatol 2002; 118(6): 1038-43.
  • 20. Rosai J. Respiratory tract, metastatic tumors. In: Ackerman’s Surgical Pathology, 9th Edition. Mosby, New York, 2004: 422-24

LENFOMA NEDENİYLE UYGULANAN RADYOTERAPİ SONRASI SEKONDER MALİGNİTELER-OLGU SUNUMU

Yıl 2006, Cilt: 19 Sayı: 2, 80 - 85, 26.06.2015

Alper Çelik Suat Kutun Turgay Fen Gülay Bilir Akın Önder Abdullah Çetin

Öz

Bu olgu sunumunda Hodgkin lenfoma tanısıyla baş-boyun bölgesine radyoterapi uygulanmasını takiben ortaya çıkan akciğer ve çoklu cilt kanserleri tespit edilen bir olgu sunulmuştur. Elli yaşında, Evre IA Hodgkin lenfoma nedeniyle mantle alanına radyoterapi verilen erkek hastada, 6 yıl sonra burun üzerinde bazal hücreli karsinom, sağ kulak üzerinde invaziv epidermoid karsinom ve sol infraorbital bölgede in-situ epidermoid karsinom tespit edildi. Cerrahi tedavi sonrası sağ aurikuler alana ve sol infraorbital sahaya lateral cerrahi sınırın yakın olması ve hastanın re-eksizyonu kabul etmemesi nedeniyle radyoterapi verilen olgu bir yıl sonra nefes darlığı şikayeti ile başvurdu. Sağ akciğer üst ve orta zonları tutan kitle tespit edilen olgunun bronkoskobik biyopsi sonucu Epidermoid karsinom olarak rapor edildi. Vena cava superior sendromu tespit edilen hastaya tekrar radyoterapi ve medikal tedavi uygulandı. Genel durumu giderek bozulan hasta 15 gün sonra öldü.

Anahtar Kelimeler

Hodgkin lenfoma radyoterapi ikincil kanser

Kaynakça

  • 1. Panosetti E, Luboinski B, Mamelle G, et al. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study. Laryngoscope 1989; 99: 1267-73.
  • 2. Warren S, Gates O. Multiple malignant tumors: a survey of literature and statistical study. Am J Cancer 1932; 51: 1358-414.
  • 3. Van Leeuwen FE, Travis LB. Second Cancers. In: Cancer Principle and Practice of Oncolgy. DeVita VT Jr, Hellman S, Rosenberg SA, Eds, 7th Edition. WW Lippincott, Philadelphia, 2005: 2575-2602.
  • 4. Boice JD, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer – an international collaboration among cancer registries. J Natl Cancer Inst 1985; 74 (5): 955-75.
  • 5. Brenner DJ, Curtis RE, Hall EJ, et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000; 88(2): 398-406.
  • 6. Dhooge IJ, DeVos M, VanCauwenberge PB. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 1998; 108 (2): 250-6.
  • 7. Wei-wei L, Qiu-liang W, Guo-hao W, et al. Clinicopathologic features, treatment, and prognosis of postirradiation osteosarcoma in patients with nasopharyngeal cancer. Laryngoscope 2005;115(9):1574-9.
  • 8. Sanz C, Moreno F, Armas A, Casado A, Castillo MC. Groin angiosarcoma following radiotherapy for vulvar cancer. Gynecol Oncol. 2005 May;97(2):677-80.
  • 9. Eggers G, Flechtenmacher C, Kurzen H, Hassfeld S. Infiltrating basal cell carcinoma of the neck 34 years after irradiation of an haemangioma in early childhood. J Craniomaxillofac Surg 2005; 33(3):197-200.
  • 10. Van Leeuwen FE, Klokman WJ, Stovall M, et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin’s disease. J Natl Cancer Inst 1995; 87(20): 1502-3.
  • 11. Boivin JF, Hutchison GB, Zauber AG, et al. Incidence of second cancers in patients treated for Hodgkin’s disease. J Natl Cancer Inst 1995; 87(10): 732-41.
  • 12. Lorigan P, Radford J, Howell A, Thatcher N. Lung cancer after treatment for Hodgkin’s lymphoma: a systematic review. Lancet Oncol 2005; 6: 773-9.
  • 13. Kaldor J, Day N, Bell J, et al. Lung cancer following Hodgkin’s disease: a case control study. Int J Cancer 1992; 52: 677-81.
  • 14. Travis L, Gospodarowicz M, Curtis R, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst 2002; 94: 182-91.
  • 15. Gilbert E, Stowall M, Gospodarowicz M, et al. Lung cancer after treatment for Hodgkin’s disease: focus on radiation effects. Radiat Res 2003; 159: 161-73.
  • 16. Sachs RK, Brenner DJ. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci USA 2005; 102 (37): 13040-45.
  • 17. Perkins JL, Liu Y, Mitby PA, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol 2005;23 (16): 3733-41.
  • 18. Karagas MR, McDonald JA, Greenberg ER, et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 1996; 88(24):1848-53.
  • 19. Katz KA, Marcil I, Stern RS. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients. J Invest Dermatol 2002; 118(6): 1038-43.
  • 20. Rosai J. Respiratory tract, metastatic tumors. In: Ackerman’s Surgical Pathology, 9th Edition. Mosby, New York, 2004: 422-24
Toplam 20 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Olgu Sunumu
Yazarlar

Alper Çelik

Suat Kutun Bu kişi benim

Turgay Fen Bu kişi benim

Gülay Bilir Bu kişi benim

Akın Önder Bu kişi benim

Abdullah Çetin Bu kişi benim

Yayımlanma Tarihi 26 Haziran 2015
Yayımlandığı Sayı Yıl 2006 Cilt: 19 Sayı: 2

Kaynak Göster

APA Çelik, A., Kutun, S., Fen, T., Bilir, G., vd. (2015). LENFOMA NEDENİYLE UYGULANAN RADYOTERAPİ SONRASI SEKONDER MALİGNİTELER-OLGU SUNUMU. Marmara Medical Journal, 19(2), 80-85.
AMA Çelik A, Kutun S, Fen T, Bilir G, Önder A, Çetin A. LENFOMA NEDENİYLE UYGULANAN RADYOTERAPİ SONRASI SEKONDER MALİGNİTELER-OLGU SUNUMU. Marmara Med J. Ağustos 2015;19(2):80-85.
Chicago Çelik, Alper, Suat Kutun, Turgay Fen, Gülay Bilir, Akın Önder, ve Abdullah Çetin. “LENFOMA NEDENİYLE UYGULANAN RADYOTERAPİ SONRASI SEKONDER MALİGNİTELER-OLGU SUNUMU”. Marmara Medical Journal 19, sy. 2 (Ağustos 2015): 80-85.
EndNote Çelik A, Kutun S, Fen T, Bilir G, Önder A, Çetin A (01 Ağustos 2015) LENFOMA NEDENİYLE UYGULANAN RADYOTERAPİ SONRASI SEKONDER MALİGNİTELER-OLGU SUNUMU. Marmara Medical Journal 19 2 80–85.
IEEE A. Çelik, S. Kutun, T. Fen, G. Bilir, A. Önder, ve A. Çetin, “LENFOMA NEDENİYLE UYGULANAN RADYOTERAPİ SONRASI SEKONDER MALİGNİTELER-OLGU SUNUMU”, Marmara Med J, c. 19, sy. 2, ss. 80–85, 2015.
ISNAD Çelik, Alper vd. “LENFOMA NEDENİYLE UYGULANAN RADYOTERAPİ SONRASI SEKONDER MALİGNİTELER-OLGU SUNUMU”. Marmara Medical Journal 19/2 (Ağustos 2015), 80-85.
JAMA Çelik A, Kutun S, Fen T, Bilir G, Önder A, Çetin A. LENFOMA NEDENİYLE UYGULANAN RADYOTERAPİ SONRASI SEKONDER MALİGNİTELER-OLGU SUNUMU. Marmara Med J. 2015;19:80–85.
MLA Çelik, Alper vd. “LENFOMA NEDENİYLE UYGULANAN RADYOTERAPİ SONRASI SEKONDER MALİGNİTELER-OLGU SUNUMU”. Marmara Medical Journal, c. 19, sy. 2, 2015, ss. 80-85.
Vancouver Çelik A, Kutun S, Fen T, Bilir G, Önder A, Çetin A. LENFOMA NEDENİYLE UYGULANAN RADYOTERAPİ SONRASI SEKONDER MALİGNİTELER-OLGU SUNUMU. Marmara Med J. 2015;19(2):80-5.